ICAMs redistributed by chemokines to cellular uropods as a mechanism for recruitment of T lymphocytes by del Pozo, Miguel Angel et al.
 ª
 
 The Rockefeller University Press, 0021-9525/97/04/493/16 $2.00
The Journal of Cell Biology, Volume 137, Number 2, April 21, 1997 493–508 493
 
ICAMs Redistributed by Chemokines to Cellular Uropods
as a Mechanism for Recruitment of T Lymphocytes
 
Miguel Angel del Pozo,* Carlos Cabañas,
 
‡
 
 María C. Montoya,* Ann Ager,
 
§
 
 Paloma Sánchez-Mateos,
 
i
 
and Francisco Sánchez-Madrid*
 
*Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, 28006-Madrid, Spain; 
 
‡
 
Departamento de 
Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid, 28040-Madrid, Spain; 
 
§
 
National 
Institute for Medical Research, Division of Cellular Immunology, Medical Research Council, London NW7 1AA, United 
 
Kingdom; 
 
i
 
Servicio de Inmunología, Hospital General Universitario Gregorio Marañón, 28007-Madrid, Spain
 
Abstract. 
 
The recruitment of leukocytes from the 
bloodstream is a key step in the inflammatory reaction, 
and chemokines are among the main regulators of this 
process. During lymphocyte–endothelial interaction, 
chemokines induce the polarization of T lymphocytes, 
with the formation of a cytoplasmic projection (uro-
pod) and redistribution of several adhesion molecules 
(ICAM-1,-3, CD43, CD44) to this structure. Although 
it has been reported that these cytokines regulate the 
adhesive state of integrins in leukocytes, their precise 
mechanisms of chemoattraction remain to be eluci-
dated. We have herein studied the functional role of the 
lymphocyte uropod. Confocal microscopy studies 
clearly showed that cell uropods project away from the 
cell bodies of adhered lymphocytes and that polarized 
T cells contact other T cells through the uropod struc-
ture. Time-lapse videomicroscopy studies revealed that 
uropod-bearing T cells were able, through this cellular 
projection, to contact, capture, and transport additional 
bystander T cells. Quantitative analysis revealed that 
the induction of uropods results in a 5–10-fold increase 
in cell recruitment. Uropod-mediated cell recruitment 
seems to have physiological relevance, since it was 
 
promoted by both CD45R0
 
1
 
 peripheral blood memory 
T cells as well as by in vivo activated lymphocytes. Ad-
ditional studies showed that the cell recruitment medi-
ated by uropods was abrogated with antibodies to 
ICAM-1, -3, and LFA-1, whereas mAb to CD43, CD44, 
CD45, and L-selectin did not have a significant effect, 
thus indicating that the interaction of LFA-1 with 
ICAM-1 and -3 appears to be responsible for this 
process. To determine whether the increment in cell 
recruitment mediated by uropod may affect the 
transendothelial migration of T cells, we carried out 
chemotaxis assays through confluent monolayers of en-
dothelial cells specialized in lymphocyte extravasation. 
An enhancement of T cell migration was observed un-
der conditions of uropod formation, and this increase 
was prevented by incubation with either blocking anti–
ICAM-3 mAbs or drugs that impair uropod formation. 
These data indicate that the cell interactions mediated 
by cell uropods represent a cooperative mechanism in 
lymphocyte recruitment, which may act as an amplifica-
tion system in the inflammatory response.
T
 
he
 
 leukocyte adhesion to endothelium, with subse-
quent migration through the vascular wall towards
inflammatory foci, is a multistep process finely reg-
ulated by several proinflammatory factors (Springer, 1995).
During this process, circulating leukocytes roll along the
endothelium interacting with immobilized cytokines that
promote the firm adhesion and subsequent arrest of leu-
kocytes on the vessel wall. Leukocytes then migrate fol-
lowing a chemoattractant gradient and using integrins as
migration supporters, crossing the endothelial barrier and
the underlying extracellular matrix (ECM)
 
1
 
 towards the
inflammatory foci. Increasing evidence supports that chemo-
attractants can regulate the adhesive state of integrins in
leukocytes (Springer, 1995), but the mechanism(s) by
which these factors guide T lymphocyte emigration re-
main(s) unclear.
Several members of the chemokine family have recently
been identified as chemoattractants for T lymphocytes
(Schall et al., 1990, 1993; Taub et al., 1993
 
a
 
,
 
b
 
, 1995; Ta-
naka et al., 1993
 
a
 
,
 
b
 
; Carr et al., 1994; Schall and Bacon,
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1. 
 
Abbreviations used in this paper
 
: EC, endothelial cells; ECM, extracellu-
lar matrix; HEC, high endothelial cells; PBL, peripheral blood lympho-
cytes; SF, synovial fluid; TIL, tumor infiltrating lymphocytes.
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1994). These cytokines are a wide family of 70–80-aa (8–10
kD) polypeptides that have been grouped into two sub-
families, the 
 
a
 
- or “C-X-C” chemokines, including IL-8/
NAP-1, IP-10, and MGSA/gro, and the 
 
b
 
- or “C-C”
chemokines, such as RANTES, MCP-1, -2, -3, and MIP-1
 
a
 
and 
 
b
 
. Members of both subfamilies, together with lym-
photactin, are able to attract different subsets of T lympho-
cytes (Baggiolini et al., 1994; Schall and Bacon, 1994). It
has been proposed that chemokines may direct T cell mi-
gration by activating lymphocyte integrins; in this regard,
it has been described that several chemokines increase T
cell binding to endothelial cells (EC); (Tanaka et al.,
1993
 
a
 
,
 
b
 
; Taub et al., 1993
 
a
 
,
 
b
 
; Gilat et al., 1994). Moreover,
it has been shown that MCP-1 and other C-C chemokines
regulate 
 
b
 
1 integrin–dependent adhesion to ECM com-
ponents (Carr et al., 1996; Weber et al., 1996). Neverthe-
less, it seems evident that additional mechanisms must be
involved in the emigration of lymphocytes guided by
chemokines.
We have previously described the ability of certain 
 
a
 
and 
 
b
 
 chemokines to induce a dramatic change in T cell
shape. Chemokines induce the formation of a cytoplasmic
projection or uropod on lymphocytes adhered to either
EC, endothelial adhesion molecules, or ECM proteins,
where several key adhesion molecules are redistributed
(del Pozo et al., 1995; Nieto et al., 1996). Interestingly, the
engagement of some of these molecules with specific
mAbs induced a similar effect (Campanero et al., 1994;
Sánchez-Mateos et al., 1995), and therefore these mAbs
can be used as powerful tools to mimic the effect caused
by chemokines on uropod formation. In this report we
demonstrate by confocal microscopy, time-lapse videomi-
croscopy, and migration assays that lymphocyte adhesion
receptor polarization induced by chemokines can signifi-
cantly contribute to lymphocyte recruitment. These find-
ings further support that uropod-bearing leukocytes may
have a key role in inflammatory phenomena.
 
Materials and Methods
 
Cytokines and Reagents
 
Recombinant human (rh) RANTES (sp. act. 2–5 
 
3
 
 10
 
3
 
 U/mg, purity
 
.
 
97%, endotoxin level 
 
,
 
0.1 ng/
 
m
 
g cytokine) and rhMIP-1
 
b
 
 (sp. act. 1.6–
2.5 
 
3
 
 10
 
4
 
 U/mg, purity 
 
.
 
97%, endotoxin level 
 
,
 
0.1 ng/
 
m
 
g cytokine) were
purchased from R&D Systems (Minneapolis, MN). rhIL-8 (purity 
 
.
 
98%,
endotoxin level 
 
,
 
0.1 ng/
 
m
 
g cytokine), rhMCP-1 (purity 
 
.
 
99%), and
rhMIP-1
 
a
 
 (purity 
 
.
 
99%, endotoxin level 
 
,
 
0.1 ng/
 
m
 
g cytokine) were ob-
tained from PeproTech EC Ltd. (London, UK). Butanedione monoxime,
colchicine, and PMA were purchased from Sigma Chemical Co. (St.
Louis, MO).
 
mAbs
 
The anti–ICAM-3 HP2/19, TP1/24, TP1/25, 140.11, ICR2.1, anti–ICAM-1
Hu5/3, anti–CD18 Lia3/2, anti–CD11a YTH81.5, anti–CD43 TP1/36, anti–
CD44 HP2/9, anti–CD45 D3/9, anti–CD45RA RP1/11, anti–CD45RO
UCHL.1, and anti–
 
l
 
-selectin (CD62L) LAM1/3 mAb used have been de-
scribed (Spertini et al., 1991; Campanero et al., 1993; Arroyo et al., 1994;
del Pozo et al., 1995; Juan et al., 1994; Landis et al., 1994; Luscinskas et al.,
1994; Sadhu et al., 1994). P3X63 myeloma protein (IgG
 
1
 
, 
 
k
 
) was used as
negative control.
 
Protein Substrata
 
Recombinant chimeric ICAM-1–Fc and VCAM-1-4D–Fc, consisting of the
total extracellular domains fused to IgG
 
1
 
 Fc fragment, were obtained as
described (del Pozo et al., 1995). Briefly, COS-7 cells were transiently trans-
fected with pICAM-1–Fc and pVCAM-1-4D–Fc (ICAM-1 and VCAM-1-4D
cDNAs cloned in pCD8IgG1). After 4 d, culture supernatants were pre-
cipitated with ammonium sulphate, and thereafter, chimeric proteins were
isolated by using protein A coupled to Sepharose (Pharmacia Fine Chem-
icals, Uppsala, Sweden). Fibronectin was purchased from Sigma Chemical
Co. BSA was purchased from Boehringer Mannheim GmbH (Mannheim,
Germany).
 
Cells and Cell Lines
 
Resting peripheral blood lymphocytes (PBL) were isolated from fresh hu-
man blood by Ficoll-Hypaque density gradient centrifugation (Pharmacia
Fine Chemicals), followed by two steps of adherence incubation on plastic
flasks (Costar Corp., Cambridge, MA) at 37
 
8
 
C for 1 h. CD45RA
 
1
 
 and
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CD45R0
 
1
 
 T cells were prepared by exhaustive negative selection from
freshly isolated PBL using anti–CD45RO UCHL.1 or anti–CD45RA RP1/
11 mAb, respectively, and immunomagnetic beads (Dynal Inc., Oslo, Nor-
way) as described (Vartdal et al., 1987). Paired peripheral blood and syn-
ovial fluid (SF) lymphocytes were obtained from patients with rheumatoid
arthritis (Department of Rheumatology, Hospital de la Princesa, Madrid,
Spain). Human T lymphoblasts were prepared from peripheral blood mono-
nuclear cells by treatment with phytohemagglutinin (PHA) 0.5% (Phar-
Figure 1. Cell uropods emerge away from the flattened cell bodies of adhered lymphocytes and are projected to the outer milieu. (a)
Confocal fluorescence microscopy analysis of the spatial orientation of the uropod and ICAM-3 localization on T lymphoblasts adhering
to ICAM-1–coated surfaces. T cells labeled with the fluorescence cytoplasmic probe CFDA-SE (green fluorescence) were allowed to
bind to coverslips coated with 10 mg/ml of ICAM-1–Fc for 30 min at 378C in the presence of the uropod inducing anti–ICAM-3 HP2/19
mAb (5 mg/ml). Cells were then fixed and stained for ICAM-3 (red fluorescence) as described in Materials and Methods. Slides were an-
alyzed by confocal laser scanning microscopy, and optical sectioning was adjusted to the plane of adhesion (A and B), 7 (C and D), and
10 mm above (E and F). Optical sections correspond to 0.3 mm in thickness. (b) T lymphoblasts were allowed to adhere to ICAM-1 in
the presence (right column) or in the absence (left column) of 10 ng/ml RANTES, and samples were processed as in a. Cytoplasmic
(green fluorescence) and ICAM-3 membrane staining (red fluorescence) are shown. Optical sectioning was adjusted to the plane of adhe-
sion (A), 5 (B), and 8 mm above that plane (C).
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macia Fine Chemicals) for 48 h. Cells were washed and cultured in RPMI
1640 (Flow Laboratories, Irvine, Scotland) containing 10% FCS (Flow
Laboratories) and 50 U/ml IL-2 (kindly provided by Eurocetus). T lym-
phoblasts cultured for 7–12 d were used in all experiments. T lympho-
blasts have been extensively used to study T cell adhesion and activation
(van Kooyk et al., 1991; Dransfield et al., 1992; Campanero et al., 1993). Mela-
noma cancer cells and autologous tumor infiltrating lymphocytes (TIL)
were isolated from surgical specimens from patients with metastatic mela-
noma (Department of Pathology, Hospital Gregorio Marañón, Madrid,
Spain). Tumor cells were grown in RPMI 1640/10% FCS. TIL were cul-
tured in AIM-V medium (GIBCO BRL, Life Technologies, Ltd., Paisley,
Scotland) containing 4% Ultroser HY (Sepracor Inc., SA, Villeneuve la
Garenne, France) and 500 U/ml IL-2. The human dermal microvascular
endothelial cell line HMEC-1 has previously been described (Ades et al.,
1992) and was kindly provided by Drs. Ades and Lawley (Centers for Dis-
ease Control and Prevention and Emory University School of Medicine,
Atlanta, GA). HMEC-1 were grown in MCDB 131 medium (GIBCO
BRL) supplemented with 20% FCS, 10 ng/ml EGF (Promega Biotech,
Madison, WI), 1 
 
m
 
g/ml hydrocortisone (Sigma Chemical Co.), 20 mM
Hepes, and 10 mM 
 
l
 
-glutamine. Primary cultures of high endothelial cells
(HEC) were established from cervical lymph nodes of F
 
1
 
 hybrid rats, as
previously described (Ager, 1987). HEC were grown in RPMI 1640 con-
taining 20% FCS, and confluent cultures were serially passaged and split
1:2. For the experiments described herein, three different HEC cell lines
between passage numbers 10 and 20 were used. Previous studies have
shown that the interaction between lymphocytes and HEC is independent
of the passage number of cell cultures (Ager and Mistry, 1988).
 
Immunofluorescence and Digital Confocal Microscopy
 
Immunofluorescence experiments were performed essentially as de-
scribed (del Pozo et al., 1995). Briefly, 0.5–1 
 
3
 
 10
 
6
 
 T cells (PBL, SF lym-
phocytes, TIL, or lymphoblasts) were incubated in flat-bottomed, 24-well
plates (Costar Corp.) in a final volume of 500 
 
m
 
l complete medium on cov-
erslips coated with different protein substrata or melanoma tumor cells.
Chemokines (10 ng/ml), PMA (20 ng/ml), or 5 
 
m
 
g/ml HP2/19 mAb was
added, and cells were allowed to settle in a cell incubator at 37
 
8
 
C and 5%
CO
 
2
 
 atmosphere. After different periods of time, cells were fixed with
3.7% formaldehyde in PBS for 10 min at room temperature and rinsed in
TBS (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% NaN
 
3
 
). To visualize
different membrane adhesion molecules, cells were stained with specific
mAb. After washing, cells were incubated with a 1:50 dilution of an FITC-
labeled rabbit F(ab
 
9
 
)
 
2
 
 anti–mouse IgG (Pierce, Rockford, IL) or a 1:500
dilution of a Cy3-goat anti–mouse IgG (Amersham Life Science, Pitts-
burgh, PA). The cells were observed using a Nikon Labophot-2 photomi-
croscope with 40, 60, and 100
 
3
 
 oil immersion objectives. The proportion
of uropod-bearing cells was calculated by random choice of 10 different
fields (60
 
3
 
 objective) of each condition and direct counting of total cells
(400–500) and uropod-bearing cells. Preparations were photographed on
either Ektachrome 400 (color pictures) or TMAX 400 (black and white)
film (Kodak Co., Rochester, NY). The latter was processed to 800–1,600
ASA with TMAX developer (Kodak Co.).
Samples for confocal microscopy were prepared as for standard immu-
nofluorescence studies. T lymphoblasts were cytoplasmically labeled with
the fluorescent probe CFDA-SE, following manufacturer’s instructions
(Molecular Probes Europe BV, Leiden, The Netherlands). Labeled T
lymphoblasts were incubated in flat-bottomed, 24-well plates (Costar
Corp.) in a final volume of 500 
 
m
 
l complete medium on coverslips coated
with 10 
 
m
 
g/ml ICAM-1–Fc or a confluent monolayer of EC. Chemokines,
control antibody (P3X63), or the anti–ICAM-3 TP1/24 or HP2/19 mAb (5
 
m
 
g/ml) was added, and cells were allowed to settle in a cell incubator at
37
 
8
 
C and 5% CO
 
2
 
 for 1 h. Cells were then fixed with 3.7% formaldehyde in
PBS for 10 min at room temperature and rinsed in TBS (50 mM Tris-HCl,
pH 7.6, 150 mM NaCl, 0.1% NaN
 
3
 
). After washing, cells were incubated
with a 1:50 dilution of a Texas red–conjugated goat F(ab
 
9
 
)
 
2
 
 anti–mouse
IgG (Caltag Laboratories, So. San Francisco, CA). Confocal microscopy
analysis was performed using the confocal laser scanning system (MRC-
1000; Bio-Rad Laboratories Ltd., Hertfordshire, U.K.) and a Nikon Dia-
phot 200 inverted microscope. Images of serial cellular sections were ac-
quired with the BioRad CoMos graphical user-interface and subsequently
processed to obtain three-dimentional reconstructions using the Voxel-
View (Vital Images, Inc., Fairfield, IA) software on an Indigo computer
workstation.
Tissue distribution of ICAM-3–bearing lymphocytes was determined
using double immunofluorescence staining. Surgical biopsy specimens
were snap frozen in liquid nitrogen. 4 
 
m
 
m frozen sections were cut, air
dried, and acetone fixed. Sections were overlaid with mAb supernatants
and incubated for 30 min at room temperature in a humidified chamber.
After two washings in TBS, a 1:50 dilution of Cy3-goat anti–mouse IgG
was added. After washing, the sections were saturated with 10% nonspe-
Figure 2. Lymphocyte uropods promote cell con-
tacts between T lymphoblasts. Confocal microscopy
analysis of lymphocyte–lymphocyte interactions me-
diated by cell uropods. T lymphoblasts labeled with
the green fluorescent cytoplasmic probe CFDA-SE
were allowed to bind to ICAM-1–Fc–coated cover-
slips (10 mg/ml) for 30 min at 378C in the presence of
the uropod inducing anti–ICAM-3 HP2/19 mAb.
Cells were then fixed and stained for ICAM-3 (red
fluorescence). Slides were analyzed as described in
Materials and Methods. Optical sections were adjusted to the plane of adhesion (A and B) or 5 mm above (C and D). E corresponds to
the three-dimensional reconstruction of cells, simultaneously showing the cytoplasmic (green) and ICAM-3 (red) staining.
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Figure 3. T cells are recruited by uropod-bearing T lymphocytes. Time-lapse videomicroscopy analysis of lymphocyte–lymphocyte in-
teractions. (A and B) The chemokine RANTES and the uropod-inducing anti–ICAM-3 HP2/19 mAb induce T cells to contact, capture,
and transport other T cells through their uropods. T lymphoblasts were allowed to bind to plastic petri dishes coated with ICAM-1–Fc
and treated with the anti–ICAM-3 uropod-inducing mAb HP2/19 (Ab, 5 mg/ml), with the isotype-matched nonuropod inducing anti–
ICAM-3 TP1/24 (Aa, 5 mg/ml), or with 10 ng/ml RANTES (B) for 30 min at 378C. After addition of a second cohort of untreated T lym-
phocytes (exhibiting a phase-bright appearance readily distinguishable from the phase-dark cells of the first cohort), cell–cell interac-
tions were filmed with a time-lapse videocassette recorder for 1 h. Time frames obtained from videotape recording of one representative
experiment are shown. White arrowheads point to uropods displayed by phase-dark cells of the first layer; black arrows indicate phase-
bright T lymphocytes captured by uropod-bearing cells, while the small white arrows mark the direction of movement of the adhered
cell. (Inset) Polarized lymphocyte migrating on ICAM-1–coated surface, showing the phase-dark leading edge (L) and the phase-bright
uropod (U). (C) Measurement of cell recruitment mediated by cell uropods. T lymphoblasts were allowed to bind to plastic petri dishes
coated with VCAM-1–Fc for 30 min at 378C in the presence of medium alone, 10 ng/ml RANTES, MCP-1, MIP-1a, MIP-1b, IL-8, 20 ng/
ml PMA, or 5 mg/ml anti–ICAM-3 HP2/19 and TP1/24 mAb. After addition of a second cohort of T cells, cell–cell interactions were re-
corded for 1 h, and the recruitment index was estimated as described in Materials and Methods. Arithmetic mean 6 1 SD of three inde-
pendent experiments is shown.
cific mouse serum in TBS. To stain T lymphocytes, FITC-conjugated Leu
4 anti-CD3 mAb was used (Becton Dickinson, San Jose, CA). After wash-
ing, the sections were mounted in Mowiol (Calbiochem-Novabiochem, La
Jolla, CA), and confocal microscopy analysis of serial tissue sections was
carried out.
Time-Lapse Videomicroscopy
Video microscopy analysis was performed using a Nikon Diaphot 300 in-
verted microscope equipped with a Sony SSC-M350CE CCD black and
white videocamera coupled to a Sony SVT-5000P time lapse videocassette
recorder and a Sony PVM-1453MD video monitor. T cells (PBL, SF lym-
phocytes, TIL, or lymphoblasts) were incubated for 30 min at 378C in
35-mm plastic petri dishes (Costar Corp.) previously coated with VCAM-1,
ICAM-1 (10 mg/ml), or melanoma tumor cells from a patient, in the pres-
ence of chemokines, PMA, or anti–ICAM-3 TP1/24 or HP2/19 mAb. Af-
ter addition of a second cohort of T cells, cell–cell interactions were filmed
for 1 h under phase contrast using a 203 objective. Where indicated, cells
of either the first or the second cohort were previously incubated for addi-
tional 15 min at 378C with different blocking mAbs. Images were acquired
every 3.2 s, and sequential frames were photographed. In each experimen-
tal condition, the number of cells that were attached, spread, and moving
on the substrate (phase-dark cells), as well as the number of cell–cell in-
teractions between the uropod of adhered cells and lymphocytes from the
second cohort (phase-bright cells), was counted. The recruitment index
was expressed as number of cells of the second cohort being captured per
number of cells of the first layer adhered to the substrate.
HMEC-1 Culture on Transwell Inserts and Monolayer 
Integrity Testing
T lymphoblast migration through a confluent monolayer (HMEC-1) was
assayed in a Transwell cell culture chamber (Costar Corp.). The chemo-
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taxis chambers are separated by a polycarbonate membrane (6.5 mm
diam, 10 mm thickness and 8-mm-diam pore size). Filters were coated on
their upper surface with fibronectin and layered with HMEC-1. The lower
well of the chamber was filled with HMEC-1 culture medium. The integ-
rity of the endothelial barrier was assessed by diffusion of a trypan blue–
albumin complex across the endothelial monolayer as described
(Rotrosen and Gallin, 1986). Only cell monolayers with permeability
<0.5% were used for the transendothelial migration assays.
T Lymphoblast Transendothelial Migration Assay
All assays were performed in triplicate or quadruplicate chambers, with
T cells from a single donor and HMEC-1–covered Transwell filters from
the same batch. T lymphoblasts were poured at different concentrations to
the upper compartment of the chamber in the presence of either anti–
ICAM-3 mAbs TP1/24 (IgG2a) or HP2/19 (IgG2a) at 5 mg/ml for 30 min at
378C in a 5% CO2 atmosphere. Unbound T cells were removed, and a sec-
ond cohort of 106 51Cr-labeled T lymphoblasts was added to the upper
compartment of the chamber. After different periods of time (5 min–6 h),
the percentage of cells that migrated across the endothelial cell layer was
calculated related to the total input of 51Cr-labeled T cells. In some exper-
iments, after the induction of the uropod formation, cells of the first co-
hort were incubated for additional 15 min with different blocking mAbs.
Where indicated, lymphocytes were pretreated either with 10 mM butane-
dione monoxime or with 20 mM colchicine for 30 min at 378C, extensively
washed, and used as described above.
Microscope Assay for Lymphoblast Transmigration 
Across HEC Layers
HEC were grown to confluence in polystyrene tissue culture chamber
slides (Nunc A/S, Roskilde, Denmark). Aliquots of T lymphoblasts were
incubated with different mAb (5 mg/ml) during 15 min at 37ºC, washed,
and poured onto HEC layers. After incubating for different periods of
time, unbound lymphocytes were removed by aspiration, and the HEC
layers were washed four times in prewarmed HBSS containing 1% FBS,
fixed (1% glutaraldehyde in PBS for 20 min), and stained with 1% tolu-
idine blue. Slides were examined by two independent observers using a
Nikon Labophot-2 photomicroscope with a 603 objective. Previous stud-
ies have shown that surface-bound lymphocytes (small, round, and dark-
blue cells) and transmigrated cells (large, flattened, and light-blue cells)
can be easily distinguished in these slides (Ager and Mistry, 1988). All as-
says were run in triplicate, and the number of lymphocytes of each type
was counted in three separate fields. The migration index was calculated
as follows: number of transmigrated cells/number of cells. Preparations
were photographed using Ektachrome 400 color film (Kodak Co.).
Immunofluorescence Flow Cytometry Analysis
T cells were collected before and 5 h after transendothelial migration, in-
cubated at 48C for 30 min in PBS with the primary mAb, and washed two
Figure 4. Freshly isolated CD45RO1 lymphocytes are able to re-
cruit cells through the uropod. (A and B) Measurement of cell re-
cruitment mediated by cell uropods. The total population of PBL
(A), CD45RA1, or CD45RO1 cells (B) were allowed to bind to
plastic petri dishes coated with ICAM-1–Fc for 30 min at 378C in
the presence of medium alone, 10 ng/ml RANTES, MCP-1, MIP-
1a, MIP-1b, or IL-8. After addition of a second cohort of PBL
from the same donor, cell–cell interactions were recorded for 1 h,
and the recruitment index was estimated as described in Materi-
als and Methods. Arithmetic mean 6 1 SD of four independent
experiments performed with PBL (A) or two independent ones
with CD45RA1/CD45RO1 cells (B) is shown. (C) Freshly iso-
lated CD45RA1 (a and c) or CD45RO1 (b and d) cells were al-
lowed to bind to coverslips coated with 10 mg/ml ICAM-1–Fc for
30 min at 378C in the presence (c and d) or in the absence (a and
b) of 10 ng/ml MIP-1a. Fixed cells were then stained for ICAM-3
with TP1/24 mAb, and the proportion of uropod-bearing cells
was calculated as described in Materials and Methods. The per-
centage of polarized cells in CD45RA1 versus CD45RO1 cells
was as follows: untreated 5 vs 19%, RANTES 11 vs 29%, MCP-1
10 vs 32%, MIP-1a 3 vs 26%, MIP-1b 4 vs 22%, and IL-8 8 vs
20%. The cellular uropod and the cell contact area with the sub-
stratum were indeed in a distinct plane of focus.
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Figure 5. Lymphocyte polar-
ization occurs in vivo. (a) Lym-
phocyte polarization and
ICAM-3 redistribution to the
cellular uropod during TIL
binding to autologous mela-
noma tumor cells. TIL were
cocultured with a monolayer
of melanoma cells from the
same patient for 1 h at 378C.
Fixed cells were then stained
for ICAM-3 with TP1/24 mAb
followed by incubation with a
Cy3-goat anti–mouse IgG, as
described in Materials and
Methods. Epifluorescent and
bright field conditions were
photographed on the same
frame by double exposure. Ar-
rows point to uropods. (b) Tis-
sue distribution of ICAM-3 in
T lymphocytes that infiltrate a
tumor specimen. A tissue sec-
tion of a lung metastatic mela-
noma biopsy was double im-
munofluorescence stained for
ICAM-3 (red fluorescence)
and CD3 (green fluorescence)
as described in Materials and
Methods. Tissue sections were
analyzed by confocal laser
scanning microscopy. Serial
optical sections of 0.5 mm thick
are shown (from A to E). A
small aggregate of three lym-
phocytes connected through
the tissue is followed. Arrows
point out the area of cell–cell
contact where ICAM-3 is con-
centrated.
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times, and then FITC-conjugated goat anti–mouse F(ab9)2 (Caltag Labo-
ratories) was used as secondary antibody. The fluorescence of 2,000 cells
was measured on a FACS®can (Becton Dickinson) using Lysis II soft-
ware.
Results
Spatial Orientation of the Cellular Uropod and
ICAM-3 Distribution
To assess the spatial disposition of the cellular uropod and
the membrane distribution of ICAM-3, confocal micros-
copy analysis of fluorescent-labeled (green fluorescence)
T lymphoblasts, adhering to immobilized ICAM-1 was car-
ried out in the presence of the uropod-inducing anti–
ICAM-3 HP2/19 mAb. This mAb was employed since it is
able to mimic the effect caused by chemokines on uropod
formation (Campanero et al., 1994). We found that no
ICAM-3 signal (red fluorescence) was detected in the area
of contact between cells and protein substrate (Fig. 1 a, A
and B). Interestingly, ICAM-3 fluorescence gradually in-
creased on upper planes of uropods, displaying the highest
intensity at a distance of 7–10 mm from the plane of the
coverslip, coincident with the tips of uropods (Fig. 1 a,
C–F). Similar results were obtained in experiments in
which T cells were adhered to EC instead of ICAM-1 (data
not shown). Moreover, the same morphological changes
and ICAM-3 surface redistribution effect were observed
by using chemokines. Unstimulated lymphoblasts were
also stained as controls (Fig. 1 b). Hence, these results
show that uropods extend away from the large flattened
area of cell contact with the substratum, being well ex-
posed to the outer milieu.
The Cellular Uropod Promotes Cell–Cell Contacts
in T Lymphoblasts
The projection of uropod towards outer milieu and its high
content of several adhesion molecules further suggested
its involvement in the recruitment of free lymphocytes. To
address this point we carried out a confocal microscopy
analysis of the contacts that occur between adhered, uro-
pod-bearing lymphocytes and other T cells. Interestingly,
we found that the anchorage between those cells was lo-
cated 5 mm above of the plate level and that it was medi-
ated by the ICAM-3–bearing uropod of one cell (Fig. 2,
A–D). Three-dimensional reconstruction of all different
optical sections of the specimen and rotation of the image
clearly confirmed that the intercellular contact was medi-
ated by the uropod (Fig. 2 E). Similar cell–cell contacts
were observed when the uropod was induced by the rele-
vant physiological stimuli, the chemokines (Fig. 1 b).
T Cells Are Able to Recruit and Transport Other Cells 
Through Their Uropods
Since confocal microscopy analysis only provided a static
view of the possible functional role of uropod, we decided
to undertake a dynamic assessment of this issue through
a time-lapse phase contrast microscopy analysis. A first
layer of T cells was allowed to attach to and spread on an
ICAM-1–coated surface, and then these cells were in-
duced to develop uropods with the HP2/19 anti–ICAM-3
Figure 6. TIL are able to recruit cells through the uropod. (a)
PBL or TIL were allowed to bind to plastic petri dishes coated
with 10 mg/ml ICAM-1–Fc or 20 mg/ml FN80 for 30 min at 378C.
After addition of a second cohort of PBL, cell–cell interactions
were recorded for 1 h, and the recruitment index was estimated
as described in Materials and Methods. Arithmetic mean 6 1 SD
of three independent experiments performed with PBL and TIL
from three different donors is shown. In parallel, lymphocytes were
allowed to adhere to coverslips coated with 10 mg/ml ICAM-1–Fc
for 30 min at 378C, fixed, and stained for ICAM-3, and the pro-
portion of uropod-bearing cells was calculated as described in
Materials and Methods: on ICAM-1, PBL 3%, TIL 17%; on FN80,
PBL 5%, TIL 23%. (b) TIL were allowed to bind to plastic petri
dishes coated with a monolayer of melanoma cells from the same
patient for 1 h at 378C. A second cohort of PBL was added, and
after 1 h of incubation the specimens were fixed and stained for
ICAM-3 with TP1/24 mAb as described in Materials and Meth-
ods. Same fields from two different specimens (A and B) were
photographed under bright field (left column) and epifluorescent
(right column) conditions.
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Figure 7. Involvement of
ICAM-1 and -3 in lympho-
cyte recruitment mediated by
cell uropods. (A) T lympho-
blasts adhered for 30 min at
378C to VCAM-1–Fc coated
surfaces in the presence of 10
ng/ml RANTES were then
incubated for 15 min with the
blocking mAb anti–ICAM-3
140.11, anti–ICAM-1 Hu5/3,
anti-CD43 TP1/36, anti-
CD44 HP2/9, or anti-CD45
D3/9 before the addition of a
second cohort of T cells.
Where indicated, the latter
cells were pretreated for 15
min with the anti-b2 integrin
Lia3/2 mAb, the anti-CD11a
YTH81.5 mAb, or the anti–
L-selectin LAM1-3 mAb be-
fore addition to the first layer
of T cells. The recruitment in-
dex was calculated. Arith-
metic mean 6 1 SD of three independent experiments is shown. (B) Cells were allowed to adhere for 30 min at 378C to ICAM-1–Fc
coated petri dishes in the presence of the anti–ICAM-3 uropod-inducing mAb HP2/19 and additionally incubated for 15 min at 378C ei-
ther with the blocking anti–ICAM-3 mAbs 140.11 or ICR2.1 or with the anti-CD45 D3/9 mAb before addition of the second cohort of T
cells. Arithmetic mean 6 1 SD of two independent experiments is shown.
mAb or different chemokines. A second cohort of T cells
was then added, and cell–cell interactions were filmed. At-
tached lymphocytes in the first cohort adopted a phase-
dark morphology. Under conditions of uropod induction,
a significant proportion of cells of the second cohort, which
exhibited a phase-bright appearance readily distinguish-
able from the first cohort, were contacted, trapped, and fi-
nally engaged by cells of the first cohort (Fig. 3, A and B).
Interestingly, the adhered lymphocytes of the first cohort
were moving on the ICAM-1–coated surface, displaying
the uropod in the antipodean pole relative to the advanc-
ing front of the cell, and were transporting other T cells
engaged through the uropod (Fig. 3 B). By counting the
number of cells of the second cohort that were recruited
by cells of the first layer, it was estimated that the induc-
tion of the uropod resulted in a 5–10-fold increase in cell
recruitment (Fig. 3 C). In contrast, other stimulating agents,
such as phorbol esters, that promote integrin activation
but are unable to trigger uropod formation, failed to stim-
ulate T cell recruitment (Fig. 3 C), thus underlining the
participation of uropods in this phenomenon.
Selective Recruitment of T Cells by Peripheral
Blood CD45R01 Memory and In Vivo Activated
T Lymphocytes
Although T lymphoblasts likely represent the memory-
activated subset of T cells, the number of circulating lym-
phoblasts is very low. Therefore, we explored whether the
mechanism of cell recruitment mediated by uropods could
be observed in lymphocytes directly isolated from the blood.
Although these cells adhered nicely onto the ICAM-1–
coated surface, they moved less than activated T lympho-
blasts, and chemokines only weakly induced lymphocyte
polarization and recruitment of a second layer of unstimu-
lated peripheral blood lymphocytes (Fig. 4 A, and data not
shown). Therefore, we decided to explore whether the
recruitment was selectively exerted by a subset of the cells.
In this regard, it has recently been reported that most of
the chemokine receptors are upregulated on the CD45R01
memory-activated phenotype cells (Loetscher et al., 1996;
Mackay, 1996; Qin et al., 1996). Thus, we isolated CD45RA1
naive and CD45R01 memory peripheral blood lympho-
cytes and compared their ability to contact, engage, and
drive other lymphocytes. Chemokine-mediated T cell re-
cruitment was much more efficiently promoted by CD45R01
cells than by CD45RA1 naive cells (Fig. 4 B). Accord-
ingly, CD45R01 showed a higher polarized morphology,
both in basal conditions and after chemokine treatment (Fig.
4 C, b and d). CD45R01 cells developed a proper uropod,
and they actively locomote on the ICAM-1–coated sur-
face, whereas the CD45RA1 cells only displayed a capping
of the ICAM-3 molecule and migrated slower (Fig. 4 C
and data not shown). These data indicate that CD45R01
memory T cells responded more efficiently to chemokines
likely due to the higher expression of chemokine receptors
on these cells and therefore can account for the T cell re-
cruitment observed in the total population of freshly iso-
lated lymphocytes.
We also studied lymphocyte recruitment with physio-
logically in vivo TIL. These lymphocytes, which infiltrate
different tumors, display an in vivo activated phenotype
(CD45R01 CD691) and high levels of cytotoxicity against
autologous tumor cells (Itoh et al., 1988). Freshly prepared
TIL adhered to autologous melanoma tumor cells dis-
played a polarized morphology with ICAM-3 redistribu-
tion to the cell uropod (Fig. 5 a). Moreover, TIL were
found to be polarized, and ICAM-3 was found to be con-
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as after 15 min (Fig. 8 B). Since lymphocyte migration was
similar at 4–6 h, irrespective of the addition of uropod-induc-
ing mAb, it seems that the presence of uropods accelerates
transendothelial migration rather than causes an enhance-
ment of its overall magnitude. As expected, the enhance-
ment of transmigration was dependent on the number of
cells in the first layer of lymphocytes. Thus, 1.8 3 104 cells/
mm2 in the first layer under conditions of uropod induc-
tion, produced about a threefold enhancement in migra-
tion, compared to 4.5 3 103 lymphocytes/mm2 (Fig. 8 C).
When the role of uropod in lymphocyte migration was
studied by the migration assay described by Ager and Mis-
try (1988), using HEC, similar results were found. In this
assay, T cells were coincubated with HEC, and after dif-
ferent periods of time, the number of lymphocytes bound
to the apical surface or underneath the HEC monolayer
were counted. We have also found that the induction of
the uropod caused an important increment in the migra-
tion index in short periods of time, and that this effect van-
ished at longer times (Fig. 9 b). Interestingly, we observed
that in these assays the interaction between migrated lym-
phocytes and bound T cells was also mediated through
ICAM-3–bearing uropod structures (Fig. 9, a and c), indi-
cating that this interaction takes place during transendo-
thelial migration.
The role of uropod in lymphocyte migration was con-
firmed with blocking experiments. We found that the in-
crease in the migration was virtually abrogated by inhibi-
tion of uropod function in the first layer of T cells by using
blocking anti–ICAM-3 mAb (Fig. 10 A). In addition, the
prevention of uropod formation with the myosin-disrupt-
ing drug butanedione monoxime also blocked the incre-
ment in transendothelial migration of the second cohort of
T cells (Fig. 10 B). This drug has previously been reported
to prevent lymphocyte polarization and redistribution of
adhesion molecules to the uropod (Campanero et al., 1994;
del Pozo et al., 1995).
When we analyzed the expression of the adhesion mole-
cules that redistribute to uropods before and after migra-
tion across HMEC-1, we found that they did not show any
quantitative variation in their level of expression after
lymphocyte transmigration; moreover, migrated cells ex-
hibited a higher polarized morphology (Table I).
Discussion
Cell polarization is a complex phenomenon that results in
asymmetrical cell shape common to many cell types and
has a key role in cellular processes as diverse as activation,
differentiation, localized membrane growth, cell migra-
tion, vectorial transport of molecules across cell layers, an-
tigen presentation, and target cell recognition and killing
(Rodriguez-Boulan and Powell, 1992; Huttenlocher et al.,
1995; Drubin and Nelson, 1996; Helander et al., 1996;
Lauffenburger et al., 1996; Negulescu et al., 1996). Lym-
phocytes are among the diverse cellular types that un-
dergo polarization; activated and migrating lymphocytes
change from a spherical to a polarized cell shape, display-
ing a cytoplasmic projection termed uropod due to its sim-
ilarity with amoeboid morphology (Haston et al., 1982;
Wilkinson, 1986; Wilkinson and Higgins, 1987; Shutt et al.,
1995). We have previously described that chemotactic and
centrated in the area of cell contact in the small aggregates
of T cells that infiltrate the melanoma tissue sections (Fig.
5 b). TIL were able to induce T cell recruitment when ad-
hered to either ICAM-1– or FN80-coated surfaces (Fig.
6 a); this phenomenon was also observed when TIL ad-
hered to a monolayer of the tumor cells that these lympho-
cytes infiltrated in vivo (Fig. 6 b). Additionally, we also ex-
plored the in vivo relevance of this phenomenon in the
inflammatory disease rheumatoid arthritis. Lymphocytes
isolated from either peripheral blood or synovial fluid of
these patients were polarized when adhered to ICAM-1
(20 and 77%, respectively) and consequently, were able to
recruit peripheral blood lymphocytes of the same patient
(recruitment indexes: 0.13 and 0.37, respectively).
Involvement of ICAM-1 and ICAM-3 in Lymphocyte 
Recruitment Mediated by Cell Uropods
A panel of blocking mAbs was used to dissect the adhesion
molecules involved in the lymphocyte recruitment mediated
through uropods. We found that mAb against ICAM-1 and
-3, two molecules concentrated in the uropod, efficiently
inhibited lymphocyte recruitment (Fig. 7 A). In addition,
the blockade of LFA-1, the counterreceptor for ICAM-1
and -3 (Campanero et al., 1993), also prevented these cell–
cell interactions. Moreover, the YTH81.5 antibody that re-
acts with the I domain of the LFA-1a chain subunit and
that selectively blocks the interaction with ICAM-3 but
not with ICAM-1 (Landis et al., 1994) only produced a
partial inhibition in cell recruitment. Interestingly, anti-
bodies to CD43 and CD44, which are also concentrated in
the uropod, as well as to CD45 that it is not redistributed
(del Pozo et al., 1995) did not affect lymphocyte recruit-
ment. Although T lymphoblasts express L-selectin (90%
positive cells; mean fluorescence intensity, 188, versus neg-
ative control 5%; mean fluorescence intensity, 15), a block-
ing mAb directed to L-selectin did not exert any effect on
cell recruitment as measured in the time-lapse videomi-
croscopy assay (Fig. 7 A). On the other hand, cell recruit-
ment elicited by the HP2/19 anti–ICAM-3 mAb was abol-
ished by coincubation with either of two different blocking
anti–ICAM-3 mAbs but not with an anti-CD45 mAb (Fig.
7 B). Together, these data demonstrate that the interac-
tion of LFA-1 integrin with its ligands ICAM-1 and -3, lo-
cated in the uropod, is critical for the process of lympho-
cyte recruitment mediated through chemokine-induced
uropods.
Enhanced Lymphocyte Transendothelial Migration 
under Conditions of Uropod Induction
To explore whether the enhancement in lymphocyte inter-
actions mediated by uropods could result in an increase of
the transendothelial migration of the recruited cells, we car-
ried out migration assays using a modified Boyden cham-
ber (Transwell®; Costar Corp.) and confluent monolayers
of dermal microvascular endothelial cells (HMEC-1). We
found that the induction of uropod formation in the first
layer of T cells, adhered to EC, resulted in a significant en-
hancement of transmigration of 51Cr-labeled T cells of the
second cohort (Fig. 8 A); this effect was maximal at very
short time periods (45–60 min) and was detectable as early
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proinflammatory chemokines are responsible for the in-
duction of the uropod on T cells adhered to endothelial
cells, as well as for the redistribution of certain adhesion
molecules to this structure (del Pozo et al., 1995). In this
regard, it has been reported that these cytokines induce
leukocyte chemotaxis and regulate adhesive properties of
leukocyte integrins (Tanaka et al., 1993a,b; Taub et al.,
1993a,b; Gilat et al., 1994; Schall and Bacon, 1994; Carr et
al., 1996); however, the mechanisms responsible for these
effects are poorly understood. We have found herein that
chemokine-mediated cell polarization and adhesion mole-
cule redistribution to the cellular uropod confers T lym-
phocytes the ability to capture additional cells through this
structure. This phenomenon may constitute a cooperative
mechanism that can significantly contribute to the direc-
tional guidance of leukocytes to inflammatory foci induced
by chemokines.
We previously reported that uropods induced by both
chemokines and activating mAb appear to emerge away
from the flattened cell body that is adhered to EC or ECM
substrate (Campanero et al., 1994; del Pozo et al., 1995;
Sánchez-Mateos et al., 1995;). This point was inferred from
conventional fluorescence microscopy studies in which we
moved the plane of focus through the specimen. Very in-
terestingly, we have confirmed our early observations by
using confocal laser scanning fluorescence microscopy.
This analysis allowed us to definitively conclude that the
uropod is directed to the outer milieu, being projected from
the flattened cell body, and furthermore, that this struc-
ture is able to mediate contacts among lymphocytes.
However, since confocal microscopy analysis only pro-
vided us a static approach to the understanding of the
functional role of the uropod, several key questions re-
mained undetermined. Therefore, we decided to under-
Figure 8. Effect of uropod induction on transendothelial migration of T lym-
phocytes. (A and B) Uropod induction increases transendothelial migration.
Migration of T lymphoblasts across confluent monolayers from a human der-
mal microvascular endothelial cell line (HMEC-1) was assayed in a Transwell
cell culture chamber. T lymphoblasts were allowed to bind to confluent EC
monolayers cultured on polycarbonate membranes and treated either with the
uropod-inducing mAb HP2/19 or with the noninducing anti–ICAM-3 mAb
TP1/24. A second cohort of 106 51Cr-labeled T cells was then added to the up-
per compartment of the chamber and incubated for long (A, from 45 min to 6 h)
and short (B, from 5 to 60 min) periods of time at 378C in a 5% CO2 atmo-
sphere. The percentage of cells that migrated to the lower well of the chamber
was calculated using a g counter. A representative experiment out of five inde-
pendent ones run in quadruplicate is shown. Error bars represent 6 1 SD of
values from quadruplicate Transwell chambers. (C) The increment in migra-
tion was dependent on the number of cells in the first layer of lymphocytes. In
similar experiments of transendothelial migration, different numbers of T lym-
phoblasts were incubated with the confluent EC monolayers, and migration of
a second cohort of 51Cr-labeled T cells was analyzed. Transmigration is presented as the ratio between percentage of migrated cells un-
der uropod conditions and percentage of migrated cells under nonuropod conditions. Arithmethic mean 6 1 SD of three independent
experiments is shown.
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take a dynamic assessment of this issue by using a time
lapse videocassette recorder coupled to a phase contrast
microscope. Interestingly, this analysis showed that at-
tached lymphocytes are able to move over the substrate
displaying the uropod at the back of the cell, emerging
from the most distal (antipodean) pole to the leading edge
of the cell. Hence, this cellular projection corresponds ex-
actly to the clasically defined lymphocyte uropod (Lewis,
1931; Haston et al., 1982). It is worth mentioning that we
clearly observed that the cells captured through uropods
were tightly engaged through these cellular structures and
therefore migrated together with the uropod-bearing cell.
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Very importantly, we have found that this lymphocyte re-
cruitment seems to be indeed relevant in vivo since it was
also observed when uropods were promoted by physio-
logic stimuli such as chemokines. This phenomenon was
strictly dependent on the presence of the uropod, since it
did not occur upon cell stimulation with other agents that
induce cell and integrin activation like phorbol esters, but
was unable to induce uropod formation. These data strongly
suggest that lymphocyte–lymphocyte interactions are co-
operative for cell recruitment to sites where EC have been
activated, bearing chemokines on their cell surface. On the
other hand, and although there is no precedent for capture
and transport of one leukocyte by another during transen-
dothelial migration, there are several recent papers report-
ing on the synergism between leukocyte–leukocyte inter-
actions as a novel regulatory mechanism in recruitment of
leukocytes in inflammation (Bargatze et al., 1994; Alon et al.,
Figure 9. Uropod induction increases migration across HEC.
(a) Interaction through a uropod-like structure between migrated
T cells and bound lymphocytes. D shows the usual morphology of
high endothelial vein cells. A–C show the same field photo-
graphed in a different plane of focus, from the level of HEC (A)
to the level of surface bound lymphocytes (C). E shows a differ-
ent field. White arrows point to cell–cell contacts through a uropod-
like structure. (b) T lymphoblasts preincubated with the indicated
mAb were added to confluent cultures of HEC in multichamber
polystyrene slides and incubated for different periods of time. Af-
ter washing, adherent lymphocytes were identified as either “sur-
face bound” or “transmigrated” by counterstaining with toluidine
blue and high power light microscopy; the migration index was
calculated as stated in Materials and Methods. A representative
experiment out of three independent ones run in triplicate is
shown. (c) In parallel, some specimens were stained for ICAM-3
after fixation as described in Materials and Methods. Same fields
were photographed under bright field (A) and epifluorescent (B)
conditions. Arrows point to ICAM-31 uropods.
Figure 10. T cell migration mediated by cell uropods is prevented
by blocking with anti–ICAM-3 mAbs or with drugs that impair
uropod formation. T cell migration across HMEC-1 was assayed
as described in Materials and Methods. (A) After treatment of the
first layer of T lymphoblasts with either HP2/19 (uropod) or TP1/
24 (control) anti–ICAM-3 mAbs, cells were incubated for addi-
tional 15 min with the indicated blocking mAbs. (B) Before the
incubation of the first layer of T cells with the EC monolayers,
lymphocytes were treated either with butanedione monoxime or
with colchicine for 30 min at 378C, and then the drugs were exten-
sively washed. In parallel, drug-treated lymphocytes were al-
lowed to adhere to coverslips coated with 10 mg/ml ICAM-1–Fc
for 30 min at 378C, fixed and stained for ICAM-3, and the pro-
portion of uropod-bearing cells was calculated as described in
Materials and Methods: untreated control, 11%, uropod, 76%;
butanedione monoxime control, 1%, uropod 4%; colchicine con-
trol, 40%, uropod, 81%. A representative experiment out of
three independent ones run in duplicate is shown.
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1996; Jutila and Kurk, 1996; Finger et al., 1996; Fuhlbrigge
et al., 1996). L-selectin plays an important role in these
cell–cell interactions as determined by blocking studies with
specific antibodies. However, in our experiments the block-
ade of L-selectin did not interfere with lymphocyte re-
cruitment, since we have looked at the tight adhesion be-
tween lymphocytes (b2 integrin/ICAM-1,-3–dependent)
rather than at the rolling phase observed under flow con-
ditions (selectin-dependent; Springer, 1995; Butcher and
Picker, 1996). Therefore, our results do not rule out the
possible involvement of L-selectin and its carbohydrate
ligands in the process of lymphocyte recruitment under
flow conditions. In this regard, it is worth mentioning that
the ligand of P-selectin PSGL-1, which also binds L-selec-
tin, has been detected on the uropods of activated, polar-
ized neutrophils (Lorant el al., 1995).
Altogether our findings on cell recruitment suggested that
T cell interactions through the uropod can significantly in-
crease migration through an endothelial barrier and under-
lying ECM to inflammatory foci. To further support this
point we performed specific transendothelial migration as-
says. Under conditions of uropod formation, lymphocyte
migration through dermal microvascular endothelial cells
was clearly enhanced. It is worth mentioning that most of
the previously reported assays of lymphocyte chemotaxis
have been performed using inert polycarbonate filters. At
best, endothelial cells derived from the umbilical cord vein
(HUVEC) have been used by some authors (Roth et al.,
1995; Randolph and Furie, 1996) in an attempt to model the
blood vessel wall. The use of HUVEC increases the signal
to background ratio of chemotaxis and provides a more
physiologic model of lymphocyte emigration from the blood-
stream than the conventional in vitro chemotaxis assays
lacking endothelium (Roth et al., 1995). However, it is evi-
dent that lymphocyte extravasation occurs primarily through
postcapillary venules rather than through large vessels such
as the umbilical vein. To our knowledge, this is one of the
first reports employing microvascular endothelium spe-
cialized in diapedesis in chemotaxis assays. Furthermore,
we have also studied lymphocyte migration through high
endothelial venules. The endothelial cells from high en-
dothelial venules stem from specialized postcapillary vas-
cular sites in lymphoid organs that are able to support high
levels of lymphocyte extravasation (Ager and Mistry, 1988;
Girard and Springer, 1995). Interestingly, we found that in
both systems, uropods significantly enhance T cell trans-
migration at very short time periods. In this regard, TNF-a
stimulation of HMEC-1 also rendered an initial increment
in lymphocyte migration, whereas at longer periods of
time the transmigration level was equal to nonstimulated
EC (not shown). Therefore, different phenomena such as
the generation of lymphocyte uropods or activation of
HMEC-1 by TNF-a rendered a similar effect in transendo-
thelial migration. It is worth mentioning the existence of
contacts through ICAM-3–bearing uropods during cell
transmigration. Unfortunately, we could not fully assess the
effect of exogenously applied chemokines on uropod for-
mation in our migration assays, since the presence of
chemokines in the upper compartment of the chamber
would impair lymphocyte transendothelial migration to-
wards the lower compartment by an inversion of the
chemotactic gradient generated by the dermal micro-
vascular endothelial cells. However, our clearcut results
on the effect of chemokines in T cell recruitment strongly
suggest their involvement in transendothelial migration.
Lymphocytes that are recruited into inflamed tissues
bear preferentially the memory/activated CD45R01 phe-
notype (Carr et al., 1994). It is now becoming clear that
within the T lineage, most of the chemokine receptors are
restricted to CD45R01 cells (Loetscher et al., 1996; Mac-
kay, 1996). T cells that migrate in response to RANTES,
MCP-1, and MIP-1a are mainly CD45RA2 CD45R01 mem-
ory T cells (Qin et al., 1996). In this context we have found
that these chemokines act preferentially on freshly iso-
lated CD45R01 cells inducing uropod formation, and there-
fore, these cells are able to recruit other T cells through
the uropod. Furthermore, physiologically in vivo activated
CD45R01 T lymphocytes isolated from inflammatory in-
filtrates of rheumatoid arthritis patients and TIL display-
ing a highly polarized morphology were able to recruit
T cells very efficiently. Altogether, these results provide
evidence that the mechanism of uropod-mediated lympho-
cyte recruitment has in vivo physiologic relevance.
In additional experiments of cell recruitment, we have
observed that this phenomenon is not only induced when
lymphocytes are attached to adhesion molecules expressed
by inflamed endothelium (VCAM-1 or ICAM-1) but also
to extracellular matrix proteins such as fibronectin, as shown
for TIL. In this regard, it is well known that the chemotac-
tic gradients produced by chemokines occur underneath
the endothelial barrier, and we have recently found that
uropods are efficiently promoted by chemokines on lym-
phocytes adhered to several ECM substrates (del Pozo et al.,
1995). Moreover, the adhesion molecules that redistribute
to uropods do not show any quantitative variation in their
level of expression after lymphocyte migration across
Table I. Cell Polarization and Flow Cytometric Analysis of T cells during Migration across HMEC-1
Percentage of Polarized cells* Antigen expression‡
Unstimulated RANTES P3X63 ICAM-1 ICAM-3 CD43 CD44 CD45
Before migration 1 17 4 6 2 15 6 8 134 6 41 157 6 54 428 6 145 497 6 108
After migration 24 71 4 6 1 16 6 6 141 6 40 174 6 58 421 6 139 487 6 102
Data shown are from a representative experiment out of three independent ones.
*T lymphoblasts were collected before and 5 h after migration across HMEC-1 and allowed to bind to ICAM-1–coated coverslips for 30 min at 378C in the presence or in the ab-
sence of chemokine RANTES (10 ng/ml). Fixed cells were then stained for ICAM-3, and the percentage of polarized cells (with ICAM-3 redistributed to the uropod) was calcu-
lated as previously described (del Pozo et al., 1995).
‡mAbs were used to detect surface expression of ICAM-1, -3, CD43, CD44, and CD45 on T lymphoblasts before and 5 h after migration across HMEC-1. The fluorescence was
measured on a FACS®can (Becton Dickinson), and results are expressed as a mean fluorescence intensity 6 1 SD of 2,000 cells per determination. Staining with the negative con-
trol P3X63 IgG1 myeloma protein is also shown.
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HMEC-1, and migrated cells exhibit a higher polarized cell
morphology. Therefore, it is conceivable that uropods could
also play a role in leukocyte recruitment once cells have
extravasated and are migrating towards the inflammatory
foci. In this regard, this issue is underscored by the obser-
vations that TIL adhering to a monolayer of the original
melanoma tumor cells are able to recruit other lymphocytes
through the uropod. Lymphocyte recruitment mediated by
uropods could therefore represent a general mechanism of
major importance during a wide variety of immunological
processes in which cell migration is involved.
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